# Nuclide record amir-iravani (person). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/people/amir-iravani/>
  a schema:Person ;
  nuclide:kind "person" ;
  schema:identifier "amir-iravani" ;
  schema:name "Amir Iravani"@en ;
  schema:description "A nuclear medicine physician-scientist who worked on the practice-changing TheraP and LuPSMA trials in Australia and has moved through Fred Hutchinson to UCLA in 2026 to build a new hospital theranostics programme."@en ;
  schema:url <https://nuclide.cc/people/amir-iravani/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.uclahealth.org/news/release/nuclear-medicine-physician-scientist-dr-amir-iravani-joins>, <https://www.beckershospitalreview.com/radiology/ucla-health-taps-fred-hutch-theranostics-leader/> ;
  nuclide:tag "PSMA", "theranostics", "clinician" ;
  schema:jobTitle "Associate Professor and Vice Chair of Clinical Research, Director of the Theranostics Program, Department of Nuclear Medicine and Theranostics, David Geffen School of Medicine at UCLA (from July 2026; previously Theranostics Clinical Director, Fred Hutchinson Cancer Center, and Associate Professor of Radiology, University of Washington, 2022-2026)" ;
  nuclide:related <https://nuclide.cc/trials/therap/>, <https://nuclide.cc/drugs/pluvicto/>, <https://nuclide.cc/institutions/ucla-jonsson/>, <https://nuclide.cc/isotopes/lu-177/> .